-
Diversity in renal function monitoring and dose modifications during treatment for childhood cancer: A call for standardization
Blufpand, H. N., Hes, N., Bökenkamp, A., van de Wetering, M. D. & Kaspers, G. J. L., 2014, In: Pediatric blood & cancer. 61, 2, p. 337-344Research output: Contribution to journal › Review article* › Academic › peer-review
-
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer
Knijnenburg, S. L., Mulder, R. L., Schouten-van Meeteren, A. Y. N., Bökenkamp, A., Blufpand, H., van Dulmen-den Broeder, E., Veening, M. A., Kremer, L. C. M. & Jaspers, M. W. M., 2013, In: Cochrane database of systematic reviews (Online). 2013, 10, p. CD008944 CD008944.Research output: Contribution to journal › Review article* › Academic › peer-review
-
Cystatin C more accurately detects mildly impaired renal function than creatinine in children receiving treatment for malignancy
Blufpand, H. N., Tromp, J., Abbink, F. C. H., Stoffel-Wagner, B., Bouman, A. A., Schouten-van Meeteren, A. Y. N., van Wijk, J. A. E., Kaspers, G. J. L. & Bökenkamp, A., 2011, In: Pediatric blood & cancer. 57, 2, p. 262-267Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
